Last 12 months
Inside the activity.
0 purchase rows · 25 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 8 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 20, 2017 Filed Feb 22, 2017 19:08 UTC |
WORBOYS PHILIP DSVP, Translational Science
|
Tax withholdingOrdinary Shares | 10,397 | $33.78 | $351,210.66 |
DisclosureSEC source: 0001179110-17-002996 · edgar.xml · nonDerivative · entry 1 WORBOYS PHILIP D · CIK 0001668718 · SVP, Translational Science 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,935 Read SEC document |
| February 20, 2017 Filed Feb 22, 2017 19:07 UTC |
PITZER KENNETH RSVP, Prod Strat & Comm Plng
|
Tax withholdingOrdinary Shares | 10,030 | $33.78 | $338,813.40 |
DisclosureSEC source: 0001179110-17-002993 · edgar.xml · nonDerivative · entry 1 PITZER KENNETH R · CIK 0001668775 · SVP, Prod Strat & Comm Plng 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,347 Read SEC document |
| February 20, 2017 Filed Feb 22, 2017 19:07 UTC |
Shafer Bradford JEVP, Gen. Counsel, Secretary
|
Tax withholdingOrdinary Shares | 12,440 | $33.78 | $420,223.20 |
DisclosureSEC source: 0001179110-17-002994 · edgar.xml · nonDerivative · entry 1 Shafer Bradford J · CIK 0001302448 · EVP, Gen. Counsel, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,282 Read SEC document |
| February 20, 2017 Filed Feb 23, 2017 00:08 UTC |
Winningham Rick EDirector · Chief Executive Officer
|
Tax withholdingOrdinary Shares | 33,264 | $33.78 | $1,123,657.92 |
DisclosureSEC source: 0001179110-17-002995 · edgar.xml · nonDerivative · entry 1 Winningham Rick E · CIK 0001302443 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 870,135 Read SEC document |
| February 20, 2017 Filed Feb 23, 2017 00:05 UTC |
GALA RENEE DSVP, Chief Financial Officer
|
Tax withholdingOrdinary Shares | 10,211 | $33.78 | $344,927.58 |
DisclosureSEC source: 0001179110-17-002988 · edgar.xml · nonDerivative · entry 1 GALA RENEE D · CIK 0001607737 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,350 Read SEC document |
| February 20, 2017 Filed Feb 23, 2017 00:07 UTC |
PASQUALONE FRANKSVP Global Head Acute Care Bus
|
Tax withholdingOrdinary Shares | 8,762 | $33.78 | $295,980.36 |
DisclosureSEC source: 0001179110-17-002992 · edgar.xml · nonDerivative · entry 1 PASQUALONE FRANK · CIK 0001597334 · SVP Global Head Acute Care Bus 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,118 Read SEC document |
| February 20, 2017 Filed Feb 23, 2017 00:06 UTC |
LEE JUNNINGSr. VP, Technical Operations
|
Tax withholdingOrdinary Shares | 9,611 | $33.78 | $324,659.58 |
DisclosureSEC source: 0001179110-17-002991 · edgar.xml · nonDerivative · entry 1 LEE JUNNING · CIK 0001596187 · Sr. VP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,071 Read SEC document |
| February 20, 2017 Filed Feb 23, 2017 00:06 UTC |
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc
|
Tax withholdingOrdinary Shares | 14,434 | $33.78 | $487,580.52 |
DisclosureSEC source: 0001179110-17-002989 · edgar.xml · nonDerivative · entry 1 HAUMANN BRETT K · CIK 0001607733 · SVP Clin Dev & Chief Med Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,471 Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 19:10 UTC |
WORBOYS PHILIP DSVP, Translational Science
|
GrantOrdinary Shares | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-002004 · edgar.xml · nonDerivative · entry 1 WORBOYS PHILIP D · CIK 0001668718 · SVP, Translational Science 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,332 Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 19:08 UTC |
PITZER KENNETH RSVP, Prod Strat & Comm Plng
|
GrantOrdinary Shares | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-002001 · edgar.xml · nonDerivative · entry 1 PITZER KENNETH R · CIK 0001668775 · SVP, Prod Strat & Comm Plng 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,377 Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 19:07 UTC |
HEGDE SHARATHCHANDRA SSVP, Research
|
GrantOrdinary Shares | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-001999 · edgar.xml · nonDerivative · entry 1 HEGDE SHARATHCHANDRA S · CIK 0001668696 · SVP, Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,628 Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 19:09 UTC |
Shafer Bradford JEVP, Gen. Counsel, Secretary
|
GrantOrdinary Shares | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-002002 · edgar.xml · nonDerivative · entry 1 Shafer Bradford J · CIK 0001302448 · EVP, Gen. Counsel, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,722 Read SEC document |
| February 06, 2017 Filed Feb 9, 2017 00:10 UTC |
Winningham Rick EDirector · Chief Executive Officer
|
GrantOrdinary Shares | 28,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-002003 · edgar.xml · nonDerivative · entry 1 Winningham Rick E · CIK 0001302443 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 903,399 Read SEC document |
| February 06, 2017 Filed Feb 9, 2017 00:08 UTC |
PASQUALONE FRANKSVP Global Head Acute Care Bus
|
GrantOrdinary Shares | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-002000 · edgar.xml · nonDerivative · entry 1 PASQUALONE FRANK · CIK 0001597334 · SVP Global Head Acute Care Bus 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,880 F1 · balance_after: Includes 1,702 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 13, 2016. Read SEC document |
| February 06, 2017 Filed Feb 9, 2017 00:06 UTC |
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc
|
GrantOrdinary Shares | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-001998 · edgar.xml · nonDerivative · entry 1 HAUMANN BRETT K · CIK 0001607733 · SVP Clin Dev & Chief Med Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,905 Read SEC document |
| February 06, 2017 Filed Feb 9, 2017 00:05 UTC |
GALA RENEE DSVP, Chief Financial Officer
|
GrantOrdinary Shares | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-001997 · edgar.xml · nonDerivative · entry 1 GALA RENEE D · CIK 0001607737 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,561 Read SEC document |
| November 20, 2016 Filed Nov 22, 2016 18:03 UTC |
HEGDE SHARATHCHANDRA SSVP, Research
|
Tax withholdingOrdinary Shares | 1,845 | $31.96 | $58,966.20 |
DisclosureSEC source: 0001179110-16-031977 · edgar.xml · nonDerivative · entry 1 HEGDE SHARATHCHANDRA S · CIK 0001668696 · SVP, Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,628 Read SEC document |
| November 20, 2016 Filed Nov 22, 2016 18:07 UTC |
WORBOYS PHILIP DSVP, Translational Science
|
Tax withholdingOrdinary Shares | 2,104 | $31.96 | $67,243.84 |
DisclosureSEC source: 0001179110-16-031983 · edgar.xml · nonDerivative · entry 1 WORBOYS PHILIP D · CIK 0001668718 · SVP, Translational Science 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,332 Read SEC document |
| November 20, 2016 Filed Nov 22, 2016 18:04 UTC |
PITZER KENNETH RSVP, Prod Strat & Comm Plng
|
Tax withholdingOrdinary Shares | 1,727 | $31.96 | $55,194.92 |
DisclosureSEC source: 0001179110-16-031979 · edgar.xml · nonDerivative · entry 1 PITZER KENNETH R · CIK 0001668775 · SVP, Prod Strat & Comm Plng 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,377 Read SEC document |
| November 20, 2016 Filed Nov 22, 2016 18:04 UTC |
Shafer Bradford JEVP, Gen. Counsel, Secretary
|
Tax withholdingOrdinary Shares | 4,008 | $31.96 | $128,095.68 |
DisclosureSEC source: 0001179110-16-031980 · edgar.xml · nonDerivative · entry 1 Shafer Bradford J · CIK 0001302448 · EVP, Gen. Counsel, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,722 Read SEC document |
| November 20, 2016 Filed Nov 22, 2016 23:06 UTC |
Winningham Rick EDirector · Chief Executive Officer
|
Tax withholdingOrdinary Shares | 8,360 | $31.96 | $267,185.60 |
DisclosureSEC source: 0001179110-16-031982 · edgar.xml · nonDerivative · entry 1 Winningham Rick E · CIK 0001302443 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 875,399 F1 · balance_after: Includes 1,703 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 13, 2016. Read SEC document |
| November 20, 2016 Filed Nov 22, 2016 23:03 UTC |
LEE JUNNINGSr. VP, Technical Operations
|
Tax withholdingOrdinary Shares | 3,785 | $31.96 | $120,968.60 |
DisclosureSEC source: 0001179110-16-031978 · edgar.xml · nonDerivative · entry 1 LEE JUNNING · CIK 0001596187 · Sr. VP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,682 Read SEC document |
| November 20, 2016 Filed Nov 22, 2016 23:01 UTC |
GALA RENEE DSVP, Chief Financial Officer
|
Tax withholdingOrdinary Shares | 4,628 | $31.96 | $147,910.88 |
DisclosureSEC source: 0001179110-16-031975 · edgar.xml · nonDerivative · entry 1 GALA RENEE D · CIK 0001607737 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,561 Read SEC document |
| November 20, 2016 Filed Nov 22, 2016 23:02 UTC |
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc
|
Tax withholdingOrdinary Shares | 5,388 | $31.96 | $172,200.48 |
DisclosureSEC source: 0001179110-16-031976 · edgar.xml · nonDerivative · entry 1 HAUMANN BRETT K · CIK 0001607733 · SVP Clin Dev & Chief Med Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,905 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.